6 months ago
MNMD
AnalystsBrian AbrahamsBrian Abrahams's Stock Forecasts
AnalystsBrian Abrahams
Analyst Ranking
Top 6%
#257 out of 4676 analysts
Average Return
+10.04%
Win Rate
49%100 out of 205
Risk vs Reward
Poor
Good
Brian Abrahams's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
89bio IncETNB | +558.80% | $2.67 | $17.59 | 2022-05-12 - 2023-05-11 | Buy |
Pliant Therapeutics IncPLRX | +382.01% | $4.67 | $22.51 | 2022-05-10 - 2023-05-09 | Buy |
Ambrx Biopharma IncAMAM | +233.33% | $8.40 | $28.00 | 2023-10-23 - 2024-03-06 | Buy |
Mind Medicine IncMNMD | +222.26% | $3.01 | $9.70 | 2023-03-10 - 2024-03-08 | Buy |
Ambrx Biopharma IncAMAM | +210.77% | $9.01 | $28.00 | 2023-11-14 - 2024-03-06 | Buy |
Brian Abrahams Analyst Color
Get additional color on Brian Abrahams's coverage of popular stocks
Brian Abrahams's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals IncREGN | 25 | Buy | $1,282.00 | +11.79% | Reiterates | a day ago |
Sarepta Therapeutics IncSRPT | 24 | Buy | $181.00 | +44.01% | Reiterates | 12 days ago |
Neumora Therapeutics IncNMRA | 4 | Buy | $29.00 | +147.23% | Reiterates | 14 days ago |
Gilead Sciences IncGILD | 22 | Hold | $74.00 | -10.90% | Maintains | 14 days ago |
Xenon Pharmaceuticals IncXENE | 13 | Buy | $55.00 | +37.19% | Reiterates | 15 days ago |
Incyte CorpINCY | 15 | Hold | $67.00 | +0.86% | Reiterates | 15 days ago |
Neurocrine Biosciences IncNBIX | 13 | Hold | $136.00 | +11.19% | Maintains | 20 days ago |
Corbus Pharmaceuticals Holdings IncCRBP | 5 | Buy | $82.00 | +61.10% | Reiterates | 21 days ago |
Igm Biosciences IncIGMS | 12 | Buy | $20.00 | +13.12% | Reiterates | a month ago |
Contineum Therapeutics IncCTNM | 2 | Buy | $32.00 | +73.91% | Maintains | a month ago |
Prothena Corp Public Ltd CoPRTA | 9 | Hold | $24.00 | +9.39% | Maintains | a month ago |
Intra Cellular Therapies IncITCI | 15 | Buy | $106.00 | +41.13% | Maintains | a month ago |
Karyopharm Therapeutics IncKPTI | 7 | Buy | $3.00 | +300.00% | Reiterates | a month ago |
89bio IncETNB | 13 | Hold | $12.00 | +43.71% | Maintains | a month ago |
Biocryst Pharmaceuticals IncBCRX | 10 | Buy | $10.00 | +26.26% | Reiterates | a month ago |
Biogen IncBIIB | 29 | Buy | $292.00 | +47.32% | Maintains | 2 months ago |
Applied Therapeutics IncAPLT | 3 | Buy | $12.00 | +158.06% | Reiterates | 2 months ago |
Vertex Pharmaceuticals IncVRTX | 43 | Hold | $421.00 | -12.52% | Maintains | 3 months ago |
Mind Medicine IncMNMD | 9 | Buy | $22.00 | +263.04% | Reiterates | 3 months ago |
Hookipa Pharma IncHOOK | 9 | Buy | $50.00 | +946.03% | Reiterates | 4 months ago |
Pliant Therapeutics IncPLRX | 11 | Buy | $45.00 | +257.14% | Maintains | 4 months ago |
Sage Therapeutics IncSAGE | 17 | Hold | $15.00 | +99.47% | Maintains | 5 months ago |
Marinus Pharmaceuticals IncMRNS | 7 | Hold | $3.00 | +93.55% | Downgrades | 5 months ago |
Ptc Therapeutics IncPTCT | 12 | Hold | $28.00 | -20.16% | Reiterates | 6 months ago |
Ambrx Biopharma IncAMAM | 3 | Buy | $32.00 | +14.29% | Maintains | 10 months ago |
Karuna Therapeutics IncKRTX | 7 | Buy | $225.00 | -31.78% | Maintains | 10 months ago |
Enanta Pharmaceuticals IncENTA | 14 | Hold | $15.00 | +28.76% | Maintains | a year ago |
Intercept Pharmaceuticals IncICPT | 11 | Hold | $19.00 | 0.00% | Maintains | a year ago |
Galapagos NvGLPG | 9 | Hold | $41.00 | N/A | Maintains | a year ago |
Atai Life Sciences NvATAI | 3 | Hold | $9.00 | N/A | Maintains | 2 years ago |
Merus NvMRUS | 3 | Hold | $33.00 | N/A | Maintains | 3 years ago |
Constellation Pharmaceuticals IncCNST | 1 | Hold | $34.00 | N/A | Downgrades | 3 years ago |
Metacrine IncMTCR | 1 | Buy | $25.00 | N/A | Initiates Coverage On | 4 years ago |
Neubase Therapeutics IncNBSE | 1 | Buy | $320.00 | N/A | Initiates Coverage On | 4 years ago |
Celgene CorpCELG | 2 | Buy | $118.00 | N/A | Downgrades | 6 years ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Strong Buy | N/A | N/A | Upgrades | 7 years ago |
Epizyme IncEPZM | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Alder Biopharmaceuticals IncALDR | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 7 years ago |
Immune Design CorpIMDZ | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 7 years ago |
Avexis IncAVXS | 1 | Hold | $92.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.